ACM
INSM icon

AlphaCrest Capital Management’s Insmed INSM Stock Holding History

AlphaCrest Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,618
Closed -$308K – 1320
2022
Q2 		$308K Sell
15,618
-11,059
-41% -$232K 0.01% 1112
2022
Q1 		$627K Buy
26,677
+14,056
+111% +$327K 0.04% 787
2021
Q4 		$344K Sell
12,621
-5,112
-29% -$146K 0.01% 1217
2021
Q3 		$488K Buy
+17,733
New +$465K 0.03% 920
2020
Q4 		– Sell
-11,500
Closed -$370K – 1193
2020
Q3 		$370K Buy
+11,500
New +$331K 0.04% 756

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AlphaCrest Capital Management's INSM Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of Insmed (INSM) in Q3 2022, closing a stake of 15,618 shares — an estimated $308K sold.

AlphaCrest Capital Management first reported a position in INSM in Q3 2020 and held it in 5 quarters. The position peaked at $627K in Q1 2022. 238 funds tracked by Wall St. Rank hold INSM as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining Insmed position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 15,618 Insmed shares in Q3 2022, an estimated $308K.
  • AlphaCrest Capital Management first reported a position in Insmed in Q3 2020 and held it in 5 quarters.
  • AlphaCrest Capital Management's Insmed position peaked at $627K in Q1 2022.
  • 238 funds tracked by Wall St. Rank held Insmed as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.